This inventor holds 1 USPTO granted patent. Top assignee: Socpra Sciences Sante Et Humaines S.e.c.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Élie Besserer-Offroy: Innovator in Macrocyclic Compounds
Introduction
Élie Besserer-Offroy is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the field of pain management through his innovative work on macrocyclic compounds. His research focuses on the development of new therapeutic options for preventing or treating pain, as well as inducing hypothermia or hypotension.
Latest Patents
Besserer-Offroy holds one patent titled "Macrocyclic Compounds and Methods of Preventing or Treating Pain." This patent describes a macrocyclic compound of a specific formula, along with compositions and kits that include this compound. His invention showcases promising potential in the medical field by providing new avenues for pain relief.
Career Highlights
Currently, Élie Besserer-Offroy is associated with Socpra Sciences Santé Et Humaines S.E.C., where he collaborates on groundbreaking research and development projects. His work has been focused on discovering and creating innovative compounds aimed at addressing various medical challenges.
Collaborations
Throughout his career, Besserer-Offroy has worked alongside talented colleagues such as Éric Marsault and Marc Sousbie. Their combined expertise enhances the research environment and paves the way for innovative solutions in health science.
Conclusion
Élie Besserer-Offroy's contributions to the field of macrocyclic compounds demonstrate the importance of innovation in medical science. His patent for preventing and treating pain highlights his commitment to improving patient care and quality of life. As he continues to collaborate with skilled professionals, the impact of his work is likely to grow, potentially transforming pain management practices in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile